Procurement & CDMO Status: Updates and Risk Mitigation

Created using ChatSlide

The update highlights the multi-year transfer progress of the PSX LGM Pharma project, with several products approved and pending approvals. Challenges include delays and supply risks, with recommendations to prioritize resources for critical approvals and develop contingency plans to mitigate risks, including addressing Fagron-related concerns.